On the origin of myeloid-derived suppressor cells

Camilla Rydberg Millrud, Caroline Bergenfelz, Karin Leandersson

Research output: Contribution to journalReview articlepeer-review

Abstract

Myeloid-derived suppressor cells (MDSCs) have a strong immunosuppressive character that allows them to regulate immune responses and hinder overt inflammatory responses. In cancer, this leads to tumor immune evasion and disease progression. MDSCs come in at least two forms: monocytic (Mo-MDSCs) and granulocytic (G-MDSCs). The classical definition of MDSCs as immature myeloid cells blocked from differentiating has been challenged by recent studies suggesting that Mo-MDSCs and G-MDSCs may represent monocytes and granulocytes that have acquired immunosuppressive properties. The molecular mechanism behind their generation and their true origins are now widely debated. In this review we discuss the different proposed mechanisms of the generation of both types of MDSCs, with a special focus on human MDSCs in cancer.

Original languageEnglish
Pages (from-to)3649-3665
Number of pages17
JournalOncotarget
Volume8
Issue number2
DOIs
Publication statusPublished - 2017

Subject classification (UKÄ)

  • Cell and Molecular Biology

Free keywords

  • Emergency myelopoiesis
  • Extramedullary
  • MDSC origin
  • Myelopoiesis
  • Reprogramming

Fingerprint

Dive into the research topics of 'On the origin of myeloid-derived suppressor cells'. Together they form a unique fingerprint.

Cite this